GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice

Nature Medicine

Volumn 17, Issue 5, 2011, Pages 566-572

  Won, Hyejung ^a   Mah, Won ^a   Kim, Eunjin ^a   Kim, Jae Won ^b   Hahm, Eun Kyoung ^a   Kim, Myoung Hwan ^a   Cho, Sukhee ^c   Kim, Jeongjin ^a   Jang, Hyeran ^a   Cho, Soo Churl ^b   Kim, Boong Nyun ^b   Shin, Min Sup ^b   Seo, Jinsoo ^c   Jeong, Jaeseung ^a   Choi, Se Young ^c   Kim, Daesoo ^a   Kang, Changwon ^a   Kim, Eunjoon ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c School of Dentistry   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMPHETAMINE; G PROTEIN COUPLED RECEPTOR KINASE INTERACTING PROTEIN 1; METHYLPHENIDATE; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE PREDISPOSITION; ELECTROENCEPHALOGRAPHY; GENE EXPRESSION; GENOTYPE; HUMAN; INTRON; LEARNING DISORDER; MEMORY DISORDER; MOUSE; NERVE CELL STIMULATION; NERVE EXCITABILITY; NONHUMAN; PHENOTYPE; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THETA RHYTHM;

MUS;

EID: 85027947415     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2330     Document Type: Article

References (60)

1. Barkley, R.A. Attention deficit hyperactivity disorder. A Handbook for Diagnosis and Treatment. 3rd ed. (Guilford, New York, 2006).
2. Swanson, J.M. et al. Etiologic subtypes of attention-deficit/ hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol. Rev. 17, 39-59 (2007). (Pubitemid 46355008)
3. Bakker, S.C. et al. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am. J. Hum. Genet. 72, 1251-1260 (2003). (Pubitemid 36530011)
4. Fisher, S.E. et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 70, 1183-1196 (2002). (Pubitemid 34450569)
5. Ogdie, M.N. et al. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am. J. Hum. Genet. 75, 661-668 (2004). (Pubitemid 39244780)
6. Ogdie, M.N. et al. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am. J. Hum. Genet. 72, 1268-1279 (2003). (Pubitemid 36530013)
7. Zhou, K. et al. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B, 1392-1398 (2008).
8. Arcos-Burgos, M. et al. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am. J. Hum. Genet. 75, 998-1014 (2004). (Pubitemid 39532070)
9. Franke, B., Neale, B.M. & Faraone, S.V. Genome-wide association studies in ADHD. Hum. Genet. 126, 13-50 (2009).
10. Premont, R.T. et al. beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc. Natl. Acad. Sci. USA 95, 14082-14087 (1998). (Pubitemid 28549324)
11. Claing, A. et al. Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. Proc. Natl. Acad. Sci. USA 97, 1119-1124 (2000). (Pubitemid 30080822)
12. Hoefen, R.J. & Berk, B.C. The multifunctional GIT family of proteins. J. Cell Sci. 119, 1469-1475 (2006). (Pubitemid 43732975)
13. Albertinazzi, C., Za, L., Paris, S. & de Curtis, I. ADP-ribosylation factor 6 and a functional PIX/p95-APP1 complex are required for Rac1B-mediated neurite outgrowth. Mol. Biol. Cell 14, 1295-1307 (2003). (Pubitemid 36547401)
14. Za, L. et al. betaPIX controls cell motility and neurite extension by regulating the distribution of GIT1. J. Cell Sci. 119, 2654-2666 (2006). (Pubitemid 44184002)
15. Segura, I., Essmann, C.L., Weinges, S. & Acker-Palmer, A. Grb4 and GIT1 transduce ephrinB reverse signals modulating spine morphogenesis and synapse formation. Nat. Neurosci. 10, 301-310 (2007).
16. Zhang, H., Webb, D.J., Asmussen, H., Niu, S. & Horwitz, A.F.A. GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J. Neurosci. 25, 3379-3388 (2005). (Pubitemid 40471346)
17. Zhang, H., Webb, D.J., Asmussen, H. & Horwitz, A.F. Synapse formation is regulated by the signaling adaptor GIT1. J. Cell Biol. 161, 131-142 (2003). (Pubitemid 36459086)
18. Menon, P. et al. Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice. Brain Res. 1317, 218-226 (2010).
19. Saneyoshi, T. et al. Activity-dependent synaptogenesis: regulation by a CaM-kinase kinase/CaM-kinase I/betaPIX signaling complex. Neuron 57, 94-107 (2008).
20. Kim, S. et al. The GIT family of proteins forms multimers and associates with the presynaptic cytomatrix protein Piccolo. J. Biol. Chem. 278, 6291-6300 (2003). (Pubitemid 36800886)
21. Ko, J. et al. Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting. J. Neurosci. 23, 1667-1677 (2003). (Pubitemid 36314722)
22. Schmalzigaug, R. et al. Impaired fear response in mice lacking GIT1. Neurosci. Lett. 458, 79-83 (2009).
23. Goehler, H. et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol. Cell 15, 853-865 (2004). (Pubitemid 39277983)
24. Barkley, R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol. Bull. 121, 65-94 (1997). (Pubitemid 127705285)
25. Gilden, D.L. & Hancock, H. Response variability in attention-deficit disorders. Psychol. Sci. 18, 796-802 (2007).
26. Castellanos, F.X. & Tannock, R. Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 3, 617-628 (2002). (Pubitemid 135706670)
27. Russell, V.A. Reprint of "Neurobiology of animal models of attention-deficit hyperactivity disorder." J. Neurosci. Methods 166, I-XIV (2007). (Pubitemid 350016409)
28. Gainetdinov, R.R. et al. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283, 397-401 (1999).
29. Hess, E.J., Collins, K.A. & Wilson, M.C. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J. Neurosci. 16, 3104-3111 (1996). (Pubitemid 26121853)
30. Barry, R.J., Clarke, A.R. & Johnstone, S.J. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin. Neurophysiol. 114, 171-183 (2003). (Pubitemid 36136088)
31. Düzel, E., Penny, W.D. & Burgess, N. Brain oscillations and memory. Curr. Opin. Neurobiol. 20, 143-149 (2010).
32. Uhlhaas, P.J. & Singer, W. Abnormal neural oscillations and synchrony in schizophrenia. Nat. Rev. Neurosci. 11, 100-113 (2010).
33. Clarke, A.R., Barry, R.J., Bond, D., McCarthy, R. & Selikowitz, M. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl.) 164, 277-284 (2002). (Pubitemid 35340994)
34. Feng, Q., Albeck, J.G., Cerione, R.A. & Yang, W. Regulation of the Cool/Pix proteins: key binding partners of the Cdc42/Rac targets, the p21-activated kinases. J. Biol. Chem. 277, 5644-5650 (2002). (Pubitemid 34968619)
35. Chavrier, P. & Goud, B. The role of ARF and Rab GTPases in membrane transport. Curr. Opin. Cell Biol. 11, 466-475 (1999). (Pubitemid 29396793)
36. Donaldson, J.G. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J. Biol. Chem. 278, 41573-41576 (2003). (Pubitemid 37310409)
37. Daly, G., Hawi, Z., Fitzgerald, M. & Gill, M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry 4, 192-196 (1999). (Pubitemid 29163984)
38. LaHoste, G.J. et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry 1, 121-124 (1996).
39. Bokoch, G.M. Biology of the p21-activated kinases. Annu. Rev. Biochem. 72, 743-781 (2003). (Pubitemid 36930459)
40. Boda, B., Nikonenko, I., Alberi, S. & Muller, D. Central nervous system functions of PAK protein family: from spine morphogenesis to mental retardation. Mol. Neurobiol. 34, 67-80 (2006). (Pubitemid 44465452)
41. Meyer, D.K. et al. Regulation of somatodendritic GABAA receptor channels in rat hippocampal neurons: evidence for a role of the small GTPase Rac1. J. Neurosci. 20, 6743-6751 (2000).
42. Cobos, I., Borello, U. & Rubenstein, J.L. Dlx transcription factors promote migration through repression of axon and dendrite growth. Neuron 54, 873-888 (2007). (Pubitemid 46907500)
43. Richter, K. et al. Presynaptic cytomatrix protein bassoon is localized at both excitatory and inhibitory synapses of rat brain. J. Comp. Neurol. 408, 437-448 (1999). (Pubitemid 29211193)
44. Barkley, R.A. A review of stimulant drug research with hyperactive children. J. Child Psychol. Psychiatry 18, 137-165 (1977). (Pubitemid 8092156)
45. Rosa-Neto, P. et al. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 25, 868-876 (2005). (Pubitemid 40461725)
46. Südhof, T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-911 (2008).
47. Tabuchi, K. et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71-76 (2007). (Pubitemid 47538032)
48. Deutsch, S.I., Rosse, R.B., Schwartz, B.L. & Mastropaolo, J. A revised excitotoxic hypothesis of schizophrenia: therapeutic implications. Clin. Neuropharmacol. 24, 43-49 (2001). (Pubitemid 32176480)
49. Fernandez, F. et al. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat. Neurosci. 10, 411-413 (2007). (Pubitemid 46494581)
50. Kleschevnikov, A.M. et al. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J. Neurosci. 24, 8153-8160 (2004).
51. Costa, R.M. et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415, 526-530 (2002). (Pubitemid 34130607)
52. Cui, Y. et al. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135, 549-560 (2008).
53. Shilyansky, C. et al. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc. Natl. Acad. Sci. USA 107, 13141-13146 (2010).
54. Kalanithi, P.S. et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc. Natl. Acad. Sci. USA 102, 13307-13312 (2005). (Pubitemid 41325019)
55. Moll, G.H., Heinrich, H. & Rothenberger, A. Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta Psychiatr. Scand. 107, 69-72 (2003). (Pubitemid 36092247)
56. Moll, G.H., Heinrich, H., Trott, G., Wirth, S. & Rothenberger, A. Deficient intra- cortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci. Lett. 284, 121-125 (2000). (Pubitemid 30193214)
57. Richter, M.M., Ehlis, A.C., Jacob, C.P. & Fallgatter, A.J. Cortical excitability in adult patients with attention-deficit/hyperactivity disorder (ADHD). Neurosci. Lett. 419, 137-141 (2007). (Pubitemid 46719659)
58. Pouget, P., Wattiez, N., Rivaud-Pechoux, S. & Gaymard, B. A fragile balance: perturbation of GABA mediated circuit in prefrontal cortex generates high intraindividual performance variability. PLoS ONE 4, e5208 (2009).
59. Kaufman, J. et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psychiatry 36, 980-988 (1997). (Pubitemid 27272932)
60. Kim, Y.S. et al. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean version (K-SADS-PL-K). Yonsei Med. J. 45, 81-89 (2004). (Pubitemid 38372291)